Cell Therapy News Volume 6.09 | Feb 21 2005

NCI and FDA Announce Research and Regulatory Review Fellowship Program Training for Tomorrow:
Building a Workforce for the New Age of Molecular Oncology Medicine
Article

‘Natural’ Breast Implants Advance
US scientists say they have made a breakthrough to produce natural breast implants using human stem cells.
 Article 1  Article 2

Cell Therapy May Reverse Type 1 Diabetes
Article

Study May Mark Advance in Diabetes Transplant Care
Doctors were able to eliminate the need for insulin injections in diabetic women for a year or more by simplifying the technique of transplanting insulin-producing cells
 Article

Young Blood Makes Muscles Spry: Discovery Will Affect Stem Cell, Tissue Engineering, & Aging Research 
Article

Nano Mechanism to Control Protein May Lead to New Protein Engineering
Article 1   Article 2

UCLA Scientists Transform HIV into Cancer-seeking Missile
Article 1  Article 2

Common Virus Becomes a New Target for Cancer Treatment
Article

Embryonic Stem Cells Treated with Growth Factor Reverse Hemophilia in Mice
Article

Reducing the Pain of Stem Cell Therapy
Article 1   Article 2

La Jolla Man Cured of Heart Disease Using Stem Cells from His Own Blood
Article

Columbia Scientists Identify Potential Therapy For Kidney Failure
Article

Stanford Gets OK to Try Human Cells in Mouse Brain
Article

Research May Hold Promise For Treating Alzheimer’s
Article

Gene Therapy Approach To Replace Hairs Restores Hearing
Article 1    Article 2

Israeli Researchers Generate Cancer-killing Molecules
Artilce

Israeli Findings Increase Chances of Successful Pig Embryonic Tissue Transplant
Artilce

‘Bone glue’ Could Reduce the Need for Bone Transplants
Article

Transplant Alternative: Organ Cells, Cartilage in Capsules
Article

IVF Embryos May Be Starved of a Vital Ingredient
Article

BUSINESS NEWS

Israel’s Teva to Partner with Gamida-Cell on New Leukaemia Cell Therapy
Article

Coriell Institute and Technion-Israel Institute of Technology Launch Joint Stem Cell Research Program
Article

Bio-Matrix Developing Coating for Stem Cell, Tissue Instruments
Article

Aastrom Biosciences Widens Stem Cell Trial
Article

Australia’s Mesoblast Signs Agreement to Produce Adult Stem Cells for Clinical Trials
Article

Biotech Jobs vs. Morality
Article

Crucell and DSM Announce PER.C6® Licensing and Service Agreement with Roche for Protein Production
Article

Free Rent An Obstacle For San Francisco Stem Cell Bid
Article

Proneuron Announces Milestone Patent for Copolymer-1 (Cop-1)
Patent expands use of Cop-1, previously approved for the treatment of MS
Article

Cellerant Therapeutics Presents Preclinical Data Demonstrating Therapeutic Benefit of Expanded Myeloid Progenitors at 2005 Tandem BMT Meetings
Article

Sigma-Aldrich Introduces the TargeTron(TM) Gene Knockout System
Article

Trial of Insegia in Pancreatic Cancer Does Not Meet Primary Endpoint
Article

Xcyte Therapies Presents Results of Two Clinical Trials of Xcellerated T Cells
Article

ZymoGenetics Reports Results With Recombinant Human Thrombin
Article

MARKET REPORTS

Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy and Immunotherapeutic Approaches to Cancer. 

“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.For more information and to order see:

Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1 Vol. 2
Cell Therapy Order Form

“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:

Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1  Vol. 2
Gene Therapy Order Form

The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.

A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents

Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents

Immunotherapy Reports Order Form

NATIONAL INSTITUTES OF HEALTH

NIH Guide for Grants and Contracts – Week Of February 18, 2005
Link

NIH Ethics Rule May Leave Room for Informal Public-Private Partnerships
Link

New Policy Calls for NIH-Funded Studies to Be Publicly Accessible
Link

NCI Releases Software Tool for Sharing Microarray Data
Link

Amendments to RFA-AI-05-001 “Leadership of HIV/AIDS Clinical Trials Networks”(NOT-AI-05-025)
Link

Notice Regarding NCI P50 Specialized Programs Of Research Excellence (SPOREs) Interim Guidelines (NOT-CA-05-013)
Link

Revised NIDA Policy Update for Mentored and Career Development Awards (K Awards) (NOT-DA-05-005)
Link

PROGRAM ANNOUNCEMENTS

Functional Links between the Immune System, Brain Function and Behavior (PA-05-054)
Link

Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the  Neurosciences (PAR-05-055)
Link

All new CBER information can be reached from the What’s New page

Draft Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications
Link

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
Link

Blood Products Advisory Committee March Meeting
Link

Cellular, Tissue and Gene Therapies Advisory Committee March Meeting
Link

For Country-Specific & International Regulatory Resources, Including Links to Regulatory Agencies Such as the FDA, EMEA, & More Click Here

NEWS & UPDATES

UNITED STATES

FDA
Bush Nominates Acting Commissioner Lester Crawford to Head FDA
Link

FDA Clinical Trial Statutory and Regulatory Requirements;Public Workshop
Link

Scientific Considerations Related to Developing Follow-On Protein Products; Reopening of Comment Period
Link

Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
Link

 
Draft Guidance for Industry: Considerations for Plasmid Deoxyribonucleic Acid Vaccines for Infectious Disease Indications
Link

Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Commitment Studies; Availability
Link

Reviewer Guidance on Conducting a Clinical Safety Review of a New Product Application and Preparing a Report on the Review; Availability
Link

AUSTRALIA & NEW ZEALAND
Australia and New Zealand Announce Start-up for the Joint Therapeutics Product Agency
Link

JOB POSTINGS IN CELL THERAPY NEWS ARE FREE!
For information on posting an opportunity email: info@connexoncreative.com

JOB POSTINGS

Acting President
San Diego, California (California Institute of Regenerative Medicine)

Cellular Production Lead Technician
Seattle, WA (Fred Hutchinson Cancer Research Center)

Director of Cell Therapy
New York, NY (New York Blood Center)

 Post Doctoral Fellow (enter Requisition Code 0408577)
Somerville, New Jersey (Ethicon)

Principal/Senior Scientist (enter Requisition Code 0408581)
Somerville, New Jersey (Ethicon)

Product Manager (Immunology)
Vancouver, BC (StemCell Technologies)

Project Manager (Research & Development) NEW!
Vancouver, BC (StemCell Technologies)

Sales Representative
Vancouver, BC (StemSoft)

Scientist (enter Requisition Code 0408593)
Somerville, New Jersey (Ethicon)

Senior Software Developer Vancouver
BC (StemSoft)

Stem Cell Specialist
Philadelphia, PA (Children’s Hospital of Philadelphia)

Quality Control Technologist
 Vancouver, BC (StemCell Technologies)

International Society for Cellular Therapy
www.celltherapy.org

International Society for Cellular Therapy Facility Sanitization Survey

Upcoming Meetings & Conferences:

2005 Cell Therapy Audioconference Series

May 3-4, 2005 Current Good Tissue Practice. Vancouver, BC
Workshop Chairs: Janice Davis-Sproul, MAS, MT (ASCP) SBB (John Hopkins University) & John McMannis, PhD (MD Anderson Cancer Center)
Email

May 4-7th, 2005 11th Annual ISCT Meeting. Vancouver, BC
Program Themes Include: Tissue Engineering, Mesenchymal Stem Cells, Immunotherapy, & Hematopoietic Stem Cells
Email

May 4-7th, 2005 Applications of Flow Cytometry in Marrow and Stem Cell Transplantation. Vancouver, BC
Email

Read Cytotherapy in 2005.  Join ISCT ($130) and receive the journal as a benefit of membership
http://www.celltherapy.org/mem_app.htm

Interested in Advertising in Cytotherapy?
For more information and advertising rates, Visit: http://www.celltherapy.org/journalrates.htm

Current Volume: Volume 6 Number 6/December 2004
Cytotherapy publishes original research, reviews, meeting reports, special focus issues and letters in the general field of cell therapy. The scope of the journal includes basic and applied research with hematopoietic and non-hematopoietic stem cells , immune cells, and antigen-presenting cells. Therapeutic topics within the scope of Cytotherapy include ex-vivo and in-vivo aspects of gene therapy, immunotherapy, stem cell transplantation and tissue regeneration. Cytotherapy particularly welcomes
contributions from researchers, clinicians, technicians and individuals involved in regulatory aspects of cell therapy.
www.cytotherapy.com